WTW

Willis Towers Watson Public
D

WTW

Arincen67/100B

Willis Towers Watson Public return on equity (ROE)

Willis Towers Watson Public's return on equity is 20.30%: net income of 1.58B USD over the last twelve months on shareholders' equity of 7.76B USD.

Today
20.30%
Average, 5 years
11.92%
Low, 5 years
-9.60%
High, 5 years
27.52%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 1.58B ÷ 7.76B = 20.30%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Willis Towers Watson Public's return on equity so high?

Net margin
16.5%
profit on each dollar of sales
Asset turnover
0.33×
sales on each dollar of assets
Equity multiplier
3.70×
assets on each dollar of equity
Return on equity
20.1%
FY2025
  • FY202516.5% × 0.33 × 3.70 = 20.1%
  • FY2024-1.0% × 0.36 × 3.49 = -1.2%
  • FY202311.1% × 0.33 × 3.06 = 11.1%
  • FY202211.4% × 0.28 × 3.17 = 10.1%
  • FY202146.9% × 0.26 × 2.64 = 31.8%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today20.30%1.58B7.76B
FY202531 Dec 202520.22%1.61B7.98B
FY202431 Dec 202415.72%1.25B7.94B
FY202331 Dec 202311.08%1.06B9.52B
FY202231 Dec 202210.22%1.02B10.02B
FY202131 Dec 202131.95%4.24B13.26B
FY202031 Dec 20209.43%1.02B10.82B
FY201931 Dec 201910.47%1.07B10.25B
FY201831 Dec 20187.26%715.00M9.85B
FY201731 Dec 20175.85%592.00M10.13B
FY201631 Dec 20163.32%330.00M9.95B
FY201531 Dec 201517.28%384.00M2.22B
FY201431 Dec 201418.79%373.00M1.99B
FY201331 Dec 201317.03%377.00M2.21B
FY201231 Dec 2012-25.49%-433.00M1.70B
FY201131 Dec 20118.75%219.00M2.50B
FY201031 Dec 201018.24%470.00M2.58B
FY200931 Dec 200920.99%457.00M2.18B
FY200831 Dec 200816.42%303.00M1.85B
FY200731 Dec 200730.36%409.00M1.35B
FY200631 Dec 200630.88%449.00M1.45B
FY200531 Dec 200524.04%300.00M1.25B
FY200431 Dec 200429.99%427.00M1.42B
FY200331 Dec 200331.27%414.00M1.32B
FY200231 Dec 200224.59%210.00M854.00M
FY200131 Dec 20010.29%2.00M696.00M
FY200031 Dec 20003.78%9.00M238.00M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Willis Towers Watson Public's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.